Cancer Campus entreprises

®

150 acres dedicated to innovative life sciences companies

Business facilities to assist innovative companies

Cancer Campus® is creating an environment – with particular emphasis on the field of oncology – in which innovative life science and healthcare companies can establish themselves and expand.

1

Business Incubator

Cancer Campus® offers innovative start-up premises close to the scientific and clinical environment of the Institut Gustave Roussy and its technology platforms. Budding entrepreneurs enjoy:

Facilities are being set up to assist innovative companies at each stage of their development: 1. An incubator platform for budding entrepreneurs (opening 2010) 2. A start-up centre and business hotel (opening September 2011) 3. A biopark of 350 000 sq meters (first buildings delivered in 2016)

Businesses are offered a broad array of services, including:

coordinated with the biotech support facilities of Paris Region partners (Genopole®, •Assistance Incuballiance, the Paris Chamber of Commerce, “Centre Francilien de l’Innovation”, National Institute for Industrial Property...) and support from the IGR’s Technology transfer affiliate (IGR&D)

1. An equipped work space 2. A personnalized business start-up and development support 3. The lively program of scientific and business events of the campus

If you would like information on the selection process, please contact us at: [email protected]

•Specific financial tools: G1J Île-de-France, Caisse des Dépôts et CDC Entreprises… Next to a top-level basic and clinical research:

•The Institut Gustave Roussy and its technology platforms •The teaching hospitals “Kremlin-Bicêtre” and Paul Brousse •The public health centre of Kremlin Bicêtre/Villejuif

The business incubator is supported by the European Union

2

Start-up centre and Business hotel

Source : Sadev 94 – Architect agency : François Leclercq

OFFICES The start-up centre/business hotel complex, with a total area of 7,500 m² (75,320 sq.ft), is the main specialist facilities in southern Paris Region for hosting innovative start-ups in the field of healthcare. Here businesses will find all the services and facilities expected of a start-up centre and business hotel. Located on the site where the IGR itself once stood – near Hôpital Paul Brousse and the laboratories of the CNRS and INSERM, less than 5 minutes from the metro station Line 7– the building is part of a development project that includes housing, a residence for students, a shopping area and a park. The contracting authority for the construction is the public-private partnership SADEV 94, with investment coming from the relevant local authorities. The building is managed by the Paris - Val-de-Marne Chamber of Commerce and its specialist subsidiary SCIEGE.

s 3 Floors : 5 340 sq.m of rentable space s Adaptable interior space (min 40 sq.m) s 50/50 : Office/Lab

SHARED SERVICES s Secure access s Meeting rooms s Cafeteria/relaxation area

THEY CHOSE VILLEJUIFBIOPARK s Esprimed: medical imaging and radioprotection s Teck2Market: support facilities for innovative s

For more information, please contact us at: [email protected]

s s s s

Real estate operation

Financial support

Management

start-ups Nodea Medical: Medtech for breast cancer screening and prevention Acanthe Biotech: cancer drug development Prestodiag: quick and early bacterial detection VigiCell: impact of pollutants and marketed products on human health and environment Eviagenics: new products and improved manufacturing processes for the chemical and pharmaceutical industry

s Shared technical rooms (i.e. rooms for freezers, products storage and waste) s Delivery area

A DEDICATED SUPPORT s Personnalized support for start-ups : financial raising, industrial property, international development... s A range of business events dedicated to biotech entrepreneurs

s Aisa therapeutics: development of pharmacological products which modulate the inflammation pathways s Anaconda pharma: targeting protein: protein interactions with small molecules in the antiviral field. s Assign group: CRO in clinical reserach (from Austria) s Theravectys: biotech with a novel vaccine platform to the treatment and prevention of infectious diseases (HIV) and cancers.

3

Bioparc

Cancer Campus® is developing a biopark of 350 000 sq meters, readily accessible and connected to the town. The Cancer Campus® biopark will feature laboratories, new technology platforms and technical facilities, businesses, higher education establishments, and residences for students and researchers. It will promote communication between researchers, clinicians and students. The first buildings, located next to the IGR, are expected from 2016. For more information, please contact us at: [email protected] The site is a natural setting for an innovative, health oriented campus of international status. Thanks to public and private financing, the campus will feature amenities including a daycare center, conference and professional training centers, sport facilities. Our aim is to develop a campus where innovation is fostered in the interests of everyone concerned: patients, medical staff, research teams, and private enterprise. In short, setting up a company or an activity on Cancer Campus® means participating in a next generation project.

A business park of 350,000 m2 connected to the town with housing and services for daily life Sources Communauté d’agglomération de Val de Bièvre SADEV 94 /Trévelo & Viger-Kohler

Cancer Campus®

The project of the Greater Paris transport network Automatic subway network Project sites Station planned

Pont de Sèvres

Versailles Chantiers

Champigny Centre

Villejuif Institut G. Roussy

PARIS SACLAY Massy Palaiseau Saclay

Orly Airport

PARIS BIOTECH VALLEY

ne

• future east-west link with an easy connections to •The La Défense business district (19 mins).

Extension of the existing Line 14: easy connection to central Paris (11 mins), the airports of Orly (7 mins) and Roissy (45 mins)

Noisy-Champs

Paris

i Se

Located a few minutes from Paris downtown, Cancer Campus® has been chosen to become a major hub in the metropolitan region. As part of the new “Greater Paris public transport network”, a metro station available on the site in 2018, will serve two lines:

Châtelet

La

Cancer Campus® is at heart of “Paris Biotech Valley”. Alongside other large-scale structuring projects such as Genopole® (Evry), Institut de la Vision and the Institut du Cerveau et de la Moelle (Paris), Cancer Campus® is, in its field, contributing to positioning Paris and the greater Paris region as one of the most attractive regions in Europe for medical innovation

Bobigny P. Picasso La Défense

• The Institut Gustave Roussy, the Assistance Publique des Hôpitaux de Paris (the AP-HP hospital network) and Paris-Sud University;

• The Paris Chamber of Commerce and Industry.

Clichy-Montfermeil

Nanterre

Since 2007, Cancer Campus® has been carried out by a non-profit organization. Its members are: • Local authorities, comprising the départment of Val-de-Marne, the town of Villejuif, the Communauté d’Agglomération (district council) of Val de Bièvre;

Saint-Denis Pleyel

ne

Se

M ar

Cancer Campus® is developing the Paris biocluster that aims at becoming an international reference in cancer medical innovation. At the heart of a world-class competitiveness cluster in life sciences (Medicen Paris Region) Cancer Campus® development strongly relies on the first-rate skills of the Comprehensive Cancer Center “Institut Gustave Roussy”, as well as those of other renown health, research and training academic institutions in Paris region.

le Bourget

e

in

La

La

where innovative therapy happens

Roissy Charles de Gaulle Airport

Evry Genopole

Prospective view of the future Cancer Campus® Future IGR

me

tro

s ta

tio

n

The Patient Resource Centre complements the site’s economic and scientific development by encouraging changes in the patient’s status from “user” to “autonomous and responsible individual”.

Source Communauté d’Agglomération de Val de Bièvre - Sadev 94 - Trévelo & Viger-Kohler

Cancer Campus® A biocluster relying on the first European comprehensive cancer center

Espace Maurice Tubiana 39 rue Camille Desmoulins 94805 Villejuif - FRANCE

[email protected] Tel. : +33 (0)1 42 11 67 73 Fax : +33 (0)1 42 11 53 11

www.cancer-campus.com Source Communauté d’Agglomération de Val de Bièvre - Sadev 94 - Trévelo & Viger-Kohler

220 clinicians-researchers skilled in all type of cancers A department dedicated to early clinical trials 12 000 new patients per year 24 % of treated patients participate to clinical research (2644 in 2011) 16 labelled research teams 300 researchers, 2800 students

131 international publications with an Impact Factor >10 (2011) A biological Ressources center A tumor bank of more than 70 000 samples A prospective collection of more than 2 000 tumors/year Programs of clinical and biological annotations

Technology platforms Integrated biology (-omics) Imaging and Cytometry Preclinical models Translational research (predictive and prognostic biomarkers)

A Technology Transfer affiliate In charge of licensing and technology transfer in the field of oncology

Our partners:

A scientific network Institutional: University of Paris-Sud 11; INSERM; CNRS; CEA In Île-de-France: CANCEROPOLE Île-de-France, REMAGUS (Institut Curie and IGR ), MEDICEN Paris Region (cluster in life sciences) In France : UNICANCER and Inca In Europe: EORTC and NOCI International privileged partners: - MD Anderson, Houston - USA; - Karolinska Institute, Stockholm-Sweden; - Royal Marsden, London -England; - Netherlands Cancer Institute, Amsterdam; - National Cancer Center of Tokyo - Japan; - Memorial Sloan-Kettering Cancer Center of New York - USA; - Hadassah medical center, Jerusalem-Israel; - Shanghai Fudan hospital.

Agreements with :

Design : www.paulmorgan.fr - Issued november 2012

A top level Clinical, Translational and Basic Research